Millions of people fall ill with the flu every year, and adults age 65 and older are at higher risk of developing serious ...

Fluzone High Dose is an inactivated influenza vaccine indicated for those aged 65 years or older against influenza disease caused by the strains of the influenza A and B subtypes contained within ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.71. Thomas Larsen: Welcome to the Q4 and Full Year 2024 Conference Call ...

2024 sales exceeded initial expectations driven by our differentiated Fluzone High-Dose and Flublok. In Q4, we also made significant progress with our vaccines pipeline with the start of six new ...

a high-dose quadrivalent inactivated split virion vaccine (Fluzone ® High-Dose Quadrivalent, Sanofi Pasteur) and IIV3-Adj, an MF59-adjuvanted trivalent inactivated subunit vaccine (Fluad ®, Seqirus).

Fluzone (influenza vaccine) has potential interactions with other medications. These interactions could affect how well the drug works or cause harmful effects. Fluzone is used in people ages 6 ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Donkey Kong Country Returns HD includes the additional content from the 3DS version. Donkey Kong Country Returns HD does sacrifice the 3D effect that was available on the 3DS version, but it does ...

Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...